Clinical Infectious Diseases

Authors

Juan Manuel González Cárdenas, ; Dayana Estefanía Sacta Rivera, ; Jonnathan David Buri Sarmiento, ; John Miguel Rodríguez Álvarez, ; Gabriela Abigail Campoverde Sigüenza, ; Giuliana Gabriela Flores Izquierdo, ; Ana Martina Pizarro Ulloa, ; Mishell Estefania Vintimilla Quevedo, ; Jacinto Eugenio Pérez Ramírez, ; Camila Estefanía Abad Espinoza, ; Marco Antonio Parra Cuenca, ; Doménica Monserrathe Matute Ortiz, ; María José Quevedo Crespo, ; María José Jiménez Puente, ; Sofía Micaela Vargas Flores, ; Emily Estefanía Torres Sanango, ; Jorge Eduardo Ávila Narváez, ; Esteban Andrés Morocho Pulla, ; María Emilia García Ortega, ; Cinthya del Rocío Idrovo Idrovo, ; Kerly Monserrath Pinos Larrea, ; Doménica Dayanara Zhagñay Segarra, ; Jefferson Alejandro Calderón Sisalima, ; Mateo Isaac Parra Calderón, ; Jhuleidy Nathaly Abad Ordoñez, ; Marcela Lissette Alcívar Zambrano, ; Jennifer Angelina Espinoza Bustos, ; Viviana Elizabeth González Merchán, ; John Anthony Velecela Cruz, ; Jorge Israel Bustos Avendaño, ; María Cristina Latacela Bravo, ; Adriana Lizeth Rivas Ordoñez, ; Juan Sebastián Urgilés Beltrán, ; Daniel Enrique Bustos Avendaño, ; Juan Josué Chacha Verdugo, ; Luis Fernando Romero Ávila,
DOI: https://doi.org/10.55204/pmea.35

Synopsis

Infections are one of the main reasons for consultation in daily practice, as well as being the cause of multiple hospital admissions. The world faces a serious crisis with antimicrobial resistance; During the last decade, the creation of new antibiotics has been elusive against multiresistant pathogens, so the mortality rate has increased due to this situation.
Health not only faces this problem with antimicrobials, it also suffers from antivirals, especially with patients with HIV, the various mutations at the viral level condition the therapeutic response.
The facts mentioned in therapeutics have suggested the creation of new approaches to solve them and these are phage therapy and nanotechnology, alternatives not only used for autoimmune or cancer diseases, their clinical use against persistent infections and against multi-resistant strains.
The early recognition of sepsis becomes one of the main objectives when caring for a patient; the establishment of early treatment represents the opportunity to obtain a higher survival rate.

Chapters

Downloads

Download data is not yet available.

References

Downloads

PDF/A

Published

April 27, 2023

Categories

Copyright (c) 2023 Juan Carlos Santillán Lima

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

How to Cite

Clinical Infectious Diseases. (2023). Puerto Madero Editorial Académica. https://doi.org/10.55204/pmea.35